Phase II study of etoposide, ifosfamide, and mitoxantrone for the treatment of resistant adult acute lymphoblastic leukemia.

Source:http://linkedlifedata.com/resource/pubmed/id/8352235

Download in:

View as

General Info

PMID
8352235